Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery

Saved in:
Bibliographic Details
Published inEuropean journal of cardio-thoracic surgery Vol. 30; no. 6; pp. 852 - 872
Main Authors Dunning, Joel, Treasure, Tom, Versteegh, Michael, Nashef, Samer A.M.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Science B.V 01.12.2006
Elsevier Science
Subjects
Adrenergic beta-Antagonists - therapeutic use
Amiodarone - therapeutic use
Anti-Arrhythmia Agents - therapeutic use
Atrial Fibrillation - etiology
Atrial Fibrillation - prevention & control
Atrial Fibrillation - therapy
Biological and medical sciences
Cardiac dysrhythmias
Cardiology. Vascular system
Evidence-Based Medicine
Heart
Humans
Magnesium - therapeutic use
Medical sciences
Postoperative Care - methods
Sotalol - therapeutic use
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Thoracic Surgical Procedures - adverse effects
Prevention
Clinical management
Arrhythmia
Heart disease
Atrial fibrillation
Cardiovascular disease
Thorax
Cardiac surgery
Excitability disorder
De novo
Recommendation
Online AccessGet full text
ISSN1010-7940
1873-734X
DOI10.1016/j.ejcts.2006.09.003

Cover

More Information
Bibliography:istex:6EBA52B4E415117F9417762B6A09BFA8B9CD162A
ark:/67375/HXZ-562TPR0T-D
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
ObjectType-Review-4
content type line 23
ISSN:1010-7940
1873-734X
DOI:10.1016/j.ejcts.2006.09.003